ADVERTISEMENT

Cervical injection of methylene blue for identification of sentinel lymph nodes in cervical cancer

OBG Management. 2016 August;28(8):16
August 2, 2016|ObGyn
Gulden Menderes;MD; Carlton L. Schwab;MD; Jonathan Black;MD;MPH; and Masoud Azodi
Author and Disclosure Information

Dr. Menderes is Fellow, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine, New Haven, Connecticut.

Dr. Schwab is Fellow, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine.

Dr. Black is a Fellow, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine.

Dr. Azodi is Professor, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences at Yale University School of Medicine.  

The authors report no financial relationships relevant to this article.

Brought to you by the Society of Gynecologic Surgeons. A 34-year-old patient with stage 1B1 squamous cell carcinoma of the cervix underwent sentinel lymph node dissection prior to hysterectomy. An ultrashort injection protocol of methylene blue into the cervix was used to identify sentinel lymph nodes. In this video, the authors illustrate a dissection technique of the right and left pelvic and para-aortic lymph nodes.

This video is brought to you by

View more videos from SGS here

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT